UBS Group »

Dianthus Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $435k 15k 30.00
2023-12-31 $4.0k 380 10.40
2023-09-30 $4.4k 319 13.67